Taha Hatab
@Taha_Hatab1
Followers
1K
Following
3K
Media
62
Statuses
555
PGY-2 @clevelandclinic @CCF_IMCHIEFS Cardiology research fellow @MethodistHosp, MD22’ @AUB_Lebanon
Joined October 2021
Truly honored to be the recipient of the graduate Level-One Award for the best first year resident across the @ClevelandClinic system! Grateful for my family, friends, and mentors who have supported me every step of the way. Happy to be part of the @CCF_IMCHIEFS family!
24
4
149
Humbled to have represented @CCF_IMCHIEFS in the @ACPIMPhysicians @OhioAcp Medical Dilemma — and to bring the gold back to the Clinic! 🏆 Couldn’t ask for a better team. Off to nationals — see you in April, San Francisco! @johnhanna0 @utkarshgoel08 @SafahKhan14
10
6
73
Excited to share our case now out in @JACCJournals Simultaneous closure of a left ventricular pseudoaneurysm and mitral valve perforation using AVP II Grateful to all co-authors and mentors Dr. @SergeHarbMD & Dr. @tavrkapadia
https://t.co/DSftiXJhUW
5
9
54
Happy to have presented our work at @crfheart #TCT2025 on the natural history of tricuspid regurgitation. Grateful for the mentorship of Dr @tavrkapadia
@CCF_IMCHIEFS
2
2
38
Happy to share our new paper out now in @AmJCardio In young adults (<50 y) on dialysis undergoing PCI, we found: 🔴 Higher bleeding events 🩸 🏥 Longer hospital stays ⚠️ Higher 1-year MACE ☠️ https://t.co/cTfpEKp2CG
0
10
42
Join us tonight!
Interested in #InternalMedicine? Join our Virtual Open House to see what makes @ClevelandClinic #IMRP one of the best places to train! 🗓️08/21/2025 at 6 PM (EST) 📍Virtual (link below) #Match2026 #IMResidency #MedStudent #Residency #MedTwitter
0
2
13
Excited to share our TTVR outcomes paper, now in press @crfshj ✅ Low in-hospital ☠️, high procedural success, improvement in QoL 🔹 EVOQUE: lower 30-day mortality vs other THVs, but higher PPM rate 🔌⚡️ Grateful for the mentorship of Dr @tavrkapadia! https://t.co/T2ylQYVx0O
7
7
72
Honored to be featured in the @CleClinicMD @ClevelandClinic Alumni connection! Grateful for the mentorship and friendship I’ve found at @CCF_IMCHIEFS — proud to be part of this training program! https://t.co/VFIoPI6vYw
8
4
104
Honored to present our work at @crfheart #NYValves2025—grateful for the mentorship of Dr. @tavrkapadia. Now heading back to @CCF_IMCHIEFS for my final intern MICU shift!
4
3
57
Excited to be heading back to New York for @crfheart #NYValves2025. Join me this Thursday for an interesting case on ASD closure and to know more about outcomes post TTVR!
1
3
43
Ready for #NYvalves in NYC. Excited to be part of several complex cases with masters and moderated abstracts along with amazing @tamarilomaia ! looking forward to learning from world’s best structural conference. @crfheart
@KrutarthKPandya @Taha_Hatab1 @BryanTraynor6
3
4
22
Check out our paper on the effect of M-TEER on left atrial and left ventricular functions out now in @JACCJournals
🚨Our latest research in #JACCAdvances: "Understanding the effects of M-TEER on LV function using pressure-volume loops". Key findings post M-TEER ✅ No significant change in invasive indices of LV contractility ✅Tau is significantly prolonged ✅ LV chamber stiffness remains
0
3
12
Happy to see our work on the durability of bioprosthetic surgical aortic valves led by @SyedZaidMD finally out! Thank you Drs @azeemlatib and @AndreaScotti21 for the invitation to contribute for the book! Check out the book: https://t.co/l9apiKm46x
✨ TRANSCATHETER VALVE REPLACEMENT: Valve Selection and Lifetime Management ✨ 📖 Thrilled to announce the release of this cutting-edge, up-to-date 2025 resource – co-edited by me and @azeemlatib 🔗 Explore the book here: https://t.co/1958Gtb4rb
@MontefioreNYC @EinsteinMed
0
2
24
Check out our study, out now in @JACCJournals!
This meta-analysis of 34 studies of #TAVR in aortic regurgitation (AR) demonstrated superior device success and reduced mortality, residual AR, and reintervention with dedicated TAVR devices vs off-label devices https://t.co/LVMDDEmB9J
#JACCINT #vhdAR @SachinGoelMD
3
3
33
After nearly 3 years, I'm thrilled to see this paper finally published! Led by my mentor Dr. @Koubar_Sahar , we explore attitudes and practices around Conservative Kidney Management in the MENA— a first-of-its-kind study in our region. https://t.co/vZISZE01rd
0
1
25
History 🫀
61 yrs ago today, radiologist Charles Dotter opened a blocked femoral artery with a catheter. He called it "Angioplasty." Rejected by U.S. surgeons, the concept was embraced in Europe & resulted in Gruentzig's balloon which revolutionized the treatment of CAD. #AngioHistory
0
0
7
🚨‼️🚨‼️🚨‼️🚨‼️🚨‼️ Check out our work on dedicated (@JenaValve/@JCMedicalInc) vs off-label TAVR for treating native aortic regurgitation out now in @JACCJournals!
📢 New Study in @JACCJournals TAVR in high-risk patients with native AR: Dedicated devices (JenaValve/J-Valve) deliver: ✔️ Lower 30-day mortality ✔️ Higher device success ✔️ Fewer complications (residual AR, valve migration, PPI) Read more: https://t.co/Bg68TzCX0l
1
2
27